Literature DB >> 8806520

Simian virus 40 large T antigen binds to topoisomerase I.

D T Simmons1, T Melendy, D Usher, B Stillman.   

Abstract

Binding of simian virus 40 (SV40) large T antigen to human and calf thymus topoisomerase I (topo I) was readily detected by using modified enzyme-linked immunosorbent assays and immunoblots. In addition to WT T antigen, binding could also be readily demonstrated with T antigen fragments from the amino-terminal region as well as with fragments missing this region, but much less so with small t antigen or with human p53. Antibody-blocking experiments showed that a monoclonal antibody that binds to the N-terminal region and several antibodies that recognize the central region of T antigen interfere with the binding to topo I. Our data are consistent with the existence of two separate topo I-binding regions in T antigen, one mapping within residues 82 to 246 and an apparently weaker one present after residue 246. By comparing the binding of T antigen to topo I with that of T antigen to DNA polymerase alpha or RPA, a single-stranded DNA-binding protein, it was determined that the T antigen-topo I interaction is much stronger and that the binding sites for topo I and DNA polymerase overlap, whereas the one for RPA differs. Several unwinding-defective mutants of T antigen were partially defective in their binding to topo I, suggesting that the binding to topo I is required for unwinding circular DNA. Finally, immunoprecipitation experiments demonstrated that T antigen can interact with DNA-bound topo I, indicating that such an interaction may take place during SV40 DNA replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806520     DOI: 10.1006/viro.1996.0433

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Bidirectional DNA unwinding by a ternary complex of T antigen, nucleolin and topoisomerase I.

Authors:  Stephanie Seinsoth; Heike Uhlmann-Schiffler; Hans Stahl
Journal:  EMBO Rep       Date:  2003-03       Impact factor: 8.807

2.  Schizosacchromyces pombe Dpb2 binds to origin DNA early in S phase and is required for chromosomal DNA replication.

Authors:  Wenyi Feng; Luis Rodriguez-Menocal; Gökhan Tolun; Gennaro D'Urso
Journal:  Mol Biol Cell       Date:  2003-05-18       Impact factor: 4.138

3.  Identification and cloning of two putative subunits of DNA polymerase epsilon in fission yeast.

Authors:  Maria-Grazia Spiga; Gennaro D'Urso
Journal:  Nucleic Acids Res       Date:  2004-09-23       Impact factor: 16.971

4.  Assembly of the replication initiation complex on SV40 origin DNA.

Authors:  Daniel T Simmons; Dahai Gai; Rebekah Parsons; Amanda Debes; Rupa Roy
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

Review 5.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

6.  Papillomavirus E1 protein binds to and stimulates human topoisomerase I.

Authors:  Randolph V Clower; John C Fisk; Thomas Melendy
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  A key role for Ctf4 in coupling the MCM2-7 helicase to DNA polymerase alpha within the eukaryotic replisome.

Authors:  Agnieszka Gambus; Frederick van Deursen; Dimitrios Polychronopoulos; Magdalena Foltman; Richard C Jones; Ricky D Edmondson; Arturo Calzada; Karim Labib
Journal:  EMBO J       Date:  2009-08-06       Impact factor: 11.598

8.  DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome.

Authors:  Kei Takahashi; Peter Halfmann; Masaaki Oyama; Hiroko Kozuka-Hata; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

9.  Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen.

Authors:  P Haluska; A Saleem; T K Edwards; E H Rubin
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

Review 10.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.